EUVIMEDEUVIMED entdecken
Fallbericht

Ixazomib – lenalidomide – dexamethason in heavily pretreated multiple myeloma patients – case reports

M Štork

Klinicka onkologie · 2023

DOI: 10.48095/ccko2023150 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Klinicka onkologie, 2023. Verfasst von M Štork. Hauptthemen laut MEDLINE: Multiple Myeloma. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaHumansLenalidomideDexamethasoneAntineoplastic Combined Chemotherapy ProtocolsProteasome InhibitorsBoron CompoundsGlycine

Stichwörter der Autor:innen

Kahler-Pick lawMultiple myelomaixazomibleukaemialeukemiaplasmacytomaretreatment

Substanzen

LenalidomideDexamethasoneProteasome InhibitorsixazomibBoron CompoundsGlycine

Zitieren

APA

Štork, M. (2023). Ixazomib – lenalidomide – dexamethason in heavily pretreated multiple myeloma patients – case reports. Klinicka onkologie. https://doi.org/10.48095/ccko2023150

Vancouver

Štork M. Ixazomib – lenalidomide – dexamethason in heavily pretreated multiple myeloma patients – case reports. Klinicka onkologie. 2023. doi:10.48095/ccko2023150

BibTeX
@article{tork2023,
  author = {Štork, M},
  title = {Ixazomib – lenalidomide – dexamethason in heavily pretreated multiple myeloma patients – case reports},
  journal = {Klinicka onkologie},
  year = {2023},
  doi = {10.48095/ccko2023150}
}
Kostenlos starten →